Literature DB >> 23183035

Control of MHC II antigen presentation by ubiquitination.

Jessica M Moffat1, Justine D Mintern, Jose A Villadangos.   

Abstract

MHC II antigen presentation is a critical pathway involved in the activation of the adaptive immune system. Tight regulatory controls are necessary to ensure appropriate MHC II antigen presentation. One mechanism for regulating this pathway is ubiquitination. Ubiquitination has been shown to play a critical role in fine-tuning the regulation of MHC II antigen presentation, with significant roles in antigen receptor internalisation and turnover of MHC II at the cell surface. The importance of ubiquitination is highlighted by bacterial pathogens that hijack the pathway to evade immune recognition. Understanding how ubiquitin E2 and E3 ligases contribute to controlling MHC II antigen presentation will shed light on the critical regulatory controls of this important pathway of immunity.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 23183035     DOI: 10.1016/j.coi.2012.10.008

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  9 in total

1.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

Review 2.  Prokaryotic ubiquitin-like protein modification.

Authors:  Julie A Maupin-Furlow
Journal:  Annu Rev Microbiol       Date:  2014-05-29       Impact factor: 15.500

3.  Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.

Authors:  Kyung-Jin Cho; Even Walseng; Satoshi Ishido; Paul A Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

4.  Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.

Authors:  Heeyoung Yang; Quan Qiu; Beixue Gao; Sinyi Kong; Zhenghong Lin; Deyu Fang
Journal:  J Exp Med       Date:  2014-11-03       Impact factor: 14.307

5.  An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.

Authors:  Arshad Khan; Pearl Bakhru; Subramanian Dhandayuthapani; Chinnaswamy Jagannath; Sankaralingam Saikolappan; Kishore Das; Emily Soudani; Christopher R Singh; Jaymie L Estrella; Dekai Zhang; Chandrashekhar Pasare; Yue Ma; Jianjun Sun; Jin Wang; Robert L Hunter; N Tony Eissa
Journal:  NPJ Vaccines       Date:  2019-08-05       Impact factor: 7.344

6.  Extensive remodeling of DC function by rapid maturation-induced transcriptional silencing.

Authors:  Queralt Seguín-Estévez; Isabelle Dunand-Sauthier; Sylvain Lemeille; Christian Iseli; Mark Ibberson; Vassilios Ioannidis; Christoph D Schmid; Philippe Rousseau; Emmanuèle Barras; Antoine Geinoz; Ioannis Xenarios; Hans Acha-Orbea; Walter Reith
Journal:  Nucleic Acids Res       Date:  2014-08-07       Impact factor: 16.971

7.  Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.

Authors:  Haiyin Liu; Reema Jain; Jing Guan; Vivian Vuong; Satoshi Ishido; Nicole L La Gruta; Daniel H Gray; Jose A Villadangos; Justine D Mintern
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307

8.  MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway.

Authors:  Kayla R Wilson; Haiyin Liu; Geraldine Healey; Vivian Vuong; Satoshi Ishido; Marco J Herold; Jose A Villadangos; Justine D Mintern
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

Review 9.  Potential of E3 Ubiquitin Ligases in Cancer Immunity: Opportunities and Challenges.

Authors:  Peng Ye; Xiaoxia Chi; Jong-Ho Cha; Shahang Luo; Guanghui Yang; Xiuwen Yan; Wen-Hao Yang
Journal:  Cells       Date:  2021-11-25       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.